The use of Ginkgo biloba in Raynaud's disease: A double-blind placebo-controlled trial

Vascular Medicine

Volumn 7, Issue 4, 2002, Pages 265-267

  Muir, Andrew H ^a   Robb, Rosalind ^a   McLaren, Margaret ^a   Daly, Fergus ^a   Belch, Jill J F ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Alternative medicine; Ginkgo biloba; Raynaud's disease

Indexed keywords

GINKGO BILOBA EXTRACT; PLACEBO; SEREDRIN;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COLD INJURY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GINKGO BILOBA; HEADACHE; HUMAN; INFLUENZA; MALE; MEDICAL RECORD; NAUSEA; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SINUSITIS; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; COMPLEMENTARY THERAPIES; DOUBLE-BLIND METHOD; FEMALE; GINKGO BILOBA; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLACEBO EFFECT; PLANT EXTRACTS; RAYNAUD DISEASE; TREATMENT OUTCOME;

EID: 0036981433     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x02vm455oa     Document Type: Article

References (14)

1. Porter JM, Rivers SP, Anderson CJ, Baur GM. Evaluation and management of patients with Raynaud's Syndrome. Am J Surg 1981; 142: 183-89.
2. Sunderland GT, Belch JJF, Sturrock D et al. A double blind randomised placebo-controlled trial of Hexopal in primary Raynaud's Disease. Clin Rheumatol 1988; 7: 46-49.
3. Hawkins SJ, Black CM, Hall ND et al. Clinical and laboratory effects of nifedipine in Raynaud's phenomenon. Rheumatol Int 1986; 6: 85-88.
4. Radmaker M, Cooke ED, Almond NE et al. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's Phenomenon in patients with systemic sclerosis: A double blind randomised study. Br Med J 1989; 298: 561-64.
5. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 2000; 152: 353-61.
6. Kessels AG, Sielhorst HJ, Knipschild PG. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000; 48: 1183-94.
7. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: Double blind, placebo controlled trial. BMJ 2001; 322: 73.
8. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials. Am J Med 2000; 108: 276-81.
9. Saniabadi AR, Lowe G, Belch JJF, Barbanel JC, Forbes CD. A platelet counting technique to study platelet aggregation in whole blood: Application to pathologically low platelet counts. Platelets 1990; 1: 151-53.
10. Pincemail J, Dupuis M, Nasr C et al. Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia 1989; 45: 708-12.
11. Guinot P, Caffrey E, Lambe R, Darragh A. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. Haemostasis 1989; 19: 219-23.
12. Belch JJF, Drury J, McLaughlin K et al. Abnormal biochemical and cellular parameters in the blood of patients with Raynaud's phenomenon. Scott Med J 1987; 32: 12-14.
13. Lau CS, Bridges AB, Muir A, Scott N, Bancroft A, Belch JJF. Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's Phenomenon. Br J Rhematol 1992; 31: 375-80.
14. Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo or ginseng: Nature of the evidence. Ann Pharmacother 2000; 34: 1478-82.